(Q37978566)

26 August 2017

title

The emerging role of circulating tumor cells in breast cancer (English)

1 reference

26 August 2017

author name string

Savitri Krishnamurthy

series ordinal

1

1 reference

26 August 2017

publication date

24 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

120

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

161-166

1 reference

Carcinocythemia (carcinoma cell leukemia). Report of two cases with english literature review

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Molecular basis of metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Circulating breast cancer cells are frequently apoptotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

Circulating tumor cells in patients with breast cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

7 January 2021

Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

7 January 2021

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

7 January 2021

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

7 January 2021

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20207

7 January 2021

Identifiers

DOI

10.1002/CNCY.20207

1 reference

26 August 2017

1 reference